Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Jarrett

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
The Journal of Antimicrobial Chemotherapy|June 1, 2014
Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltrationJason A Roberts, Andrew A Udy, Juergen B Bulitta, et al.
Critical Care Medicine|March 11, 2016
Glucocorticoid Sensitivity Is Highly Variable in Critically Ill Patients With Septic Shock and Is Associated With Disease SeverityJeremy Cohen, Carel J Pretorius, Jacobus P J Ungerer, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2011
Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgeryAlexandra Douglas, Andrew A Udy, Steven C Wallis, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2016
Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill PatientsAbdulaziz S Alobaid, Steven C Wallis, Paul Jarrett, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2017
Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill PatientsAbdulaziz S Alobaid, Steven C Wallis, Paul Jarrett, et al.
Journal of Critical Care|June 12, 2016
Is inhaled prophylactic heparin useful for prevention and Management of Pneumonia in ventilated ICU patients?: The IPHIVAP investigators of the Australian and New Zealand Intensive Care Society Clinical Trials GroupHiran Bandeshe, Rob Boots, Joel Dulhunty, et al.
The Journal of Investigative Dermatology|September 24, 2018
Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and CollaborationsJosef Symon S Concha, Aikaterini Patsatsi, Ann Marshak-Rothstein, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
The Journal of Antimicrobial Chemotherapy|June 1, 2014
Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltrationJason A Roberts, Andrew A Udy, Juergen B Bulitta, et al.
Critical Care Medicine|March 11, 2016
Glucocorticoid Sensitivity Is Highly Variable in Critically Ill Patients With Septic Shock and Is Associated With Disease SeverityJeremy Cohen, Carel J Pretorius, Jacobus P J Ungerer, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2011
Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgeryAlexandra Douglas, Andrew A Udy, Steven C Wallis, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2016
Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill PatientsAbdulaziz S Alobaid, Steven C Wallis, Paul Jarrett, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2017
Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill PatientsAbdulaziz S Alobaid, Steven C Wallis, Paul Jarrett, et al.
Journal of Critical Care|June 12, 2016
Is inhaled prophylactic heparin useful for prevention and Management of Pneumonia in ventilated ICU patients?: The IPHIVAP investigators of the Australian and New Zealand Intensive Care Society Clinical Trials GroupHiran Bandeshe, Rob Boots, Joel Dulhunty, et al.
The Journal of Investigative Dermatology|September 24, 2018
Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and CollaborationsJosef Symon S Concha, Aikaterini Patsatsi, Ann Marshak-Rothstein, et al.
Pageof 8